which disrupt insulin release. Sulfonylureas close these channels and restore insulin release, and have been successfully used to replace insulin treatment for patients with Kir6.2 mutations.

We aimed to avoid this bias when comparing cancer incidence in users of sulfonylurea, insulin, and other diabetes medications, respectively, with cancer incidence in metformin users. Research ...

Among 18,851 patients who ever used metformin, 15,786 (83.7%) used it as their only first diabetes medication. In contrast, sulfonylurea and insulin were often used as second- or third-line ...

Many people with type 2 diabetes can manage their blood sugar levels with lifestyle changes, including exercise and nutrition ...

Diabetes and heart health are closely connected. People with diabetes have a higher risk of heart failure, a condition where ...

Those were called sulfonylureas, the drugs that stimulate the pancreas to make more insulin. Now we have, in addition to that, drugs that improve insulin sensitivity in muscle and fat, so called ...

These oral medications push the pancreas to release more insulin. This enhances the risk of hypoglycemia, especially if someone skips meals, says the expert. Similar to sulfonylureas, meglitinides ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmac ...